C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 14/71 (2006.01) C12N 15/12 (2006.01) C12Q 1/68 (2006.01) G01N 33/50 (2006.01)
Patent
CA 2575462
The invention relates to mutations in ErbB2 gene products. The mutations described are identified in human tumours of natural origin. These mutations are associated with cancerous phenotypes and can be used as a basis for the diagnosis of cancer, cancerous cells or a predisposition to cancer in human subjects, selection of appropriate anti-cancer therapy and the development of anti-cancer therapeutics.
L'invention concerne des mutations dans des produits géniques ErbB2. Les mutations décrites sont identifiées dans des tumeurs humaines d'origine naturelle. Ces mutations sont associées à des phénotypes cancéreux et peuvent être utilisées comme base pour le diagnostic du cancer, de cellules cancéreuses ou d'une prédisposition au cancer chez des sujets humains, et pour la sélection d'un traitement anticancéreux approprié et le développement de traitements anticancéreux.
Futreal Andrew
Stratton Michael
Wooster Richard
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
The Wellcome Trust
LandOfFree
Mutations in erb2 associated with cancerous phenotypes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutations in erb2 associated with cancerous phenotypes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutations in erb2 associated with cancerous phenotypes will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1512628